BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 04/05/1998

FDA Announces Draft Guidance on Testing for Skin Sensitization to Chemicals in Latex Products

The FDA is releasing a draft guidance document to help medical device manufacturers make alternative claims for products containing natural rubber latex, replacing the 'hypoallergenic' label that will no longer be acceptable after September 30, 1998.

Source: Federal Register — Food and Drug AdministrationOpen original release →